These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Ofosu FA, Sie P, Modi GJ, Fernandez F, Buchanan MR, Blajchman MA, Boneu B, Hirsh J. Biochem J; 1987 Apr 15; 243(2):579-88. PubMed ID: 2443128 [Abstract] [Full Text] [Related]
75. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding. Hirsh J. Haemostasis; 1986 Apr 15; 16(2):82-6. PubMed ID: 3710297 [Abstract] [Full Text] [Related]
76. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T. Thromb Res; 1984 Dec 15; 36(6):633-42. PubMed ID: 6084876 [Abstract] [Full Text] [Related]
77. Low-affinity material does not contribute to the antithrombotic activity of Orgaran (Org 10172) in human plasma. Zammit A, Dawes J. Thromb Haemost; 1994 Jun 15; 71(6):759-67. PubMed ID: 7526481 [Abstract] [Full Text] [Related]
79. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas. Kindness G, Long WF, Williamson FB, Edward M, Winter JH, Bennett NB. Thromb Res; 1994 Jun 15; 17(3-4):539-44. PubMed ID: 6768163 [No Abstract] [Full Text] [Related]